Advisory Committees
-
Slides for the September 8, 2011 Meeting of the Cardiovascular and Renal Drugs Advisory Committee
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
FDA
Johnson & Johnson Pharmaceutical Research & Development
-
-







